Study #1: Pyridostigmine Improved Peak VO2 and Exercise Capacity in ME/CFS Patients
In this randomized, placebo-controlled trial at Harvard involving 45 patients with ME/CFS, pyridostigmine was found to improve peak oxygen uptake (VO2), indicating enhanced exercise capacity.
